Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

L. Orlando; M. Colleoni; F. Nolè; R. Biffi; A. Rocca; G. Curigliano; G. Ferretti; G. Peruzzotti; F. De Braud; G. Masci; A. Goldhirsch

doi:10.1023/A:1008364801718

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

L. Orlando, M. Colleoni, F. Nolè, R. Biffi, A. Rocca, G. Curigliano, G. Ferretti, G. Peruzzotti, F. De Braud, G. Masci, A. Goldhirsch

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	117-118
Number of pages	2
Journal	Annals of Oncology
Volume	11
Issue number	1
DOIs	https://doi.org/10.1023/A:1008364801718
Publication status	Published - 2000

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1023/A:1008364801718

Cite this

Orlando, L., Colleoni, M., Nolè, F., Biffi, R., Rocca, A., Curigliano, G., Ferretti, G., Peruzzotti, G., De Braud, F., Masci, G., & Goldhirsch, A. (2000). Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required? Annals of Oncology, 11(1), 117-118. https://doi.org/10.1023/A:1008364801718

Orlando, L, Colleoni, M , Nolè, F , Biffi, R , Rocca, A , Curigliano, G, Ferretti, G, Peruzzotti, G, De Braud, F , Masci, G & Goldhirsch, A 2000, 'Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?', Annals of Oncology, vol. 11, no. 1, pp. 117-118. https://doi.org/10.1023/A:1008364801718

@article{1b8fdcffedaf45c19780aa8d0fb94e83,

title = "Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?",

author = "L. Orlando and M. Colleoni and F. Nol{\`e} and R. Biffi and A. Rocca and G. Curigliano and G. Ferretti and G. Peruzzotti and {De Braud}, F. and G. Masci and A. Goldhirsch",

year = "2000",

doi = "10.1023/A:1008364801718",

language = "English",

volume = "11",

pages = "117--118",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "1",

}

TY - JOUR

T1 - Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen)

T2 - Is prophylaxis required?

AU - Orlando, L.

AU - Colleoni, M.

AU - Nolè, F.

AU - Biffi, R.

AU - Rocca, A.

AU - Curigliano, G.

AU - Ferretti, G.

AU - Peruzzotti, G.

AU - De Braud, F.

AU - Masci, G.

AU - Goldhirsch, A.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0033976384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033976384&partnerID=8YFLogxK

U2 - 10.1023/A:1008364801718

DO - 10.1023/A:1008364801718

M3 - Article

C2 - 10690401

AN - SCOPUS:0033976384

SN - 0923-7534

VL - 11

SP - 117

EP - 118

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this